← Leaderboards
Kirk R Maples
Centaur Pharmaceuticals, Inc.
$200,000
Attributed
$200,000
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$200,000 · 2
By mechanism
R43$200,000 · 2
Top collaborators
No co-investigators on record.
Most similar at Centaur Pharmaceuticals, Inc.
Same institution · by research overlap
- William A. Garland$1,958,794
Others in their field
Top investigators on “Drug Design /Synthesis /Production”
- Dennis L. Kasper · Harvard Medical School$26,605,444
- Myron Max Levine · University Of Maryland Baltimore$22,074,862
- George R Painter · Chimerix, Inc.$19,230,662
- Donald L Fine · Dynport Vaccine Company, Llc$9,996,228
- Dennis E. Hruby · Oregon State University$9,654,233
- William C Olson · Progenics Pharmaceuticals, Inc.$8,361,679
Research focus
Drug Design /Synthesis /ProductionLaboratory MouseNitroneVascular EndotheliumDrug Screening /EvaluationChemical Structure FunctionChemical SynthesisDisease /Disorder ModelHistopathologyHypoxiaInterleukin 1Laboratory RatMonocyte Chemoattractant Protein 1Neural DegenerationOxygen TransportTissue /Cell CultureTraumaTumor Necrosis Factor AlphaAtherosclerosisVascular Smooth MuscleBiotherapeutic AgentBrain Disorder ChemotherapyBrain InjuryCell Adhesion Molecules